In the News
The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.
Published: June 17, 2019
On May 15, 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adults with chronic lymphocytic leukemia (CLL) o ... More >>.
Published: June 04, 2019
Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had ... More >>.
Published: June 01, 2019
In patients with chronic lymphocytic leukemia (CLL), the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Fa ... More >>.
Published: May 10, 2019
Precision medicine centers on giving the right treatment to the right patient at the right time based on their genetic information and other characteristics. We are beginning to crack the code to apply preci ... More >>.
Published: May 03, 2019
Author: Diana Ernest, RPh
The Food and Drug Administration (FDA) has expanded the indication for Tibsovo to include treatment of newly diagnosed acute myeloid leukemia (AML) with the susceptible isocitrate dehydrogenase-1 (IDH1) muta ... More >>.
Published: April 29, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy even when all traces of the cancer appear to have gone, according to ... More >>.
Published: April 17, 2019
Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after initial diagnosis. To improve that survival rate, researchers at The University of Texas at San Antonio ... More >>.
Published: March 13, 2019
The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act, which will remove a key financial barrier that prevents some patients from accessing their prescribed cancer treatmen ... More >>.
Published: March 12, 2019
Cancer cells consume sugar at a higher rate than healthy cells, but they're also hungry for amino acids, the building blocks of proteins and other biomolecules. Researchers at Winship Cancer Institute of Emo ... More >>.
Published: February 22, 2019
Author: John Schieszer, MA
Worldwide clinical trials may greatly improve and enhance management of Hodgkin lymphoma, according to a recent article published in Clinical Medicine Insights: Oncology. Thomas J. FitzGerald, MD, a ... More >>.